List of Loseasonique drug patents

Loseasonique is owned by Teva Branded Pharm.

Loseasonique contains Ethinyl Estradiol; Levonorgestrel.

Loseasonique has a total of 3 drug patents out of which 0 drug patents have expired.

Loseasonique was authorised for market use on 24 October, 2008.

Loseasonique is available in tablet;oral dosage forms.

Loseasonique can be used as prevention of pregnancy.

The generics of Loseasonique are possible to be released after 05 December, 2028.

LOSEASONIQUE's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7615545 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Jun, 2023

(2 months from now)

US7858605 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Jun, 2023

(3 months from now)

US7855190 TEVA BRANDED PHARM Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
Dec, 2028

(5 years from now)

Drugs and Companies using ETHINYL ESTRADIOL; LEVONORGESTREL ingredient

Market Authorisation Date: 24 October, 2008

Treatment: Prevention of pregnancy

Dosage: TABLET;ORAL

How can I launch a generic of LOSEASONIQUE before it's patent expiration?
More Information on Dosage

LOSEASONIQUE family patents

18

United States

7

New Zealand

6

Japan

5

Canada

5

European Union

4

Australia

3

Russia

3

China

2

Spain

2

Brazil

2

Hong Kong

2

South Africa

2

Hungary

1

Portugal

1

Mexico

1

Cyprus

1

Slovenia

1

Bulgaria

1

Luxembourg

1

Israel

1

Poland

1

Denmark

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in